We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App


31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Groundbreaking System Combining Leadless Pacemaker with Subcutaneous Defibrillator to Revolutionize Cardiac Care

By HospiMedica International staff writers
Posted on 02 Jul 2024
Print article
Image: The new system addresses potentially dangerous problems associated with traditional pacemakers and defibrillators (Photo courtesy of Adobe Stock)
Image: The new system addresses potentially dangerous problems associated with traditional pacemakers and defibrillators (Photo courtesy of Adobe Stock)

A major complication with traditional pacemakers and defibrillators is the risk of infection, which may require the removal of the leads—insulated wires that convey electrical impulses to the heart. Additionally, these leads are susceptible to breaking, requiring their removal. Extracting leads is a complex procedure that requires specialized equipment and poses increasing risks the longer the leads are embedded in the body and the more they become integrated with heart tissue and blood vessels. Now, a new system described in an article published in the New England Journal of Medicine, marks a significant advancement in cardiac care and promises safer and more effective treatment for patients.

This groundbreaking system, developed through an international study involving dozens of researchers worldwide, including from the University of Tennessee Health Science Center (Memphis, TN, USA), combines an atrial leadless pacemaker with a novel subcutaneous defibrillator. The new devices aim to eliminate the hazardous complications associated with conventional devices by doing away with the need for lead extraction. The subcutaneous defibrillator is implanted on the left side of the body near the ribcage, with the wire routed subcutaneously and positioned above the sternum, ensuring no contact with the blood pool. Conversely, the leadless pacemaker, roughly the size of an AA battery, is implanted in the leg, led through the femoral vein and attached to the inside of the heart. These two devices communicate wirelessly to correct dangerous cardiac arrhythmias without the need for direct electrical shocks to the heart.

“When the leadless pacemaker sees a dangerous heart rhythm, it can appropriately respond to that event, it can perform antitachycardia pacing, and it can respond back to the defibrillator that it was doing that, so the defibrillator doesn’t shock the patient,” said Harish Manyam, MD, interim chair of the Department of Medicine at the University of Tennessee Health Science Center’s College of Medicine, who was part of the international study that involved dozens of researchers worldwide. “If that doesn’t work, the pacemaker will let the defibrillator know, and the defibrillator itself will shock the patient.”

Related Links:
University of Tennessee Health Science Center

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
3D HD Video Recorder

Print article


Surgical Techniques

view channel
Image: The ExcelsiusFlex and ACTIFY 3D Total Knee System have been granted FDA 510(k) clearance (Photo courtesy of Globus Medical)

New Robotic Navigation Platform Provides Surgeons Best-In-Class Solution for Orthopedic Treatment

Globus Medical (Audubon, PA, USA) has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new robotic navigation platform, ExcelsiusFlex, tailored for total knee arthroplasty... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more


view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.